The future of Pharmacovigilance
Pharma companies have historically controlled the information about drugs and their range. However, adoption of sensors, wearables and digital services has weakened this control.
Incorporating digital technology offers Pharma companies the opportunity to deliver efficiency, speed and quality of the pharmacovigilance process. The combination of patient generated health data and machine learning models offers the chance to generate accurate insights and improve drug safety & efficacy.
Pharma companies can exploit this opportunity with the right offshore partner to manage the significant pharmacovigilance shift, changes in legislation and safety of user data.
Pharmacovigilance will continue to play an influential part in new drug development and forms the core of the life science mission. As the world battles with pandemic and rising lifestyle diseases, the role of pharmacovigilance is bound to play a crucial oversight role.
Contact Us